Navigation Links
Scientists uncover how the brain controls what the eyes see
Date:11/20/2007

ented with objects in which the direction of motion was ambiguous, or undefined, and asked to identify the main direction of motion.

The pattern of neural activity in the MT region was highly similar when an observer viewed real motion moving to the left and when they thought they saw the ambiguously moving objects moving to the left.

The close correspondence between the pattern of activation in MT and what the observer reports seeing suggests that this region of your brain plays an important role in generating conscious experience of the world around you, Serences said.


'/>"/>

Contact: Heather Wuebker
hwuebker@uci.edu
949-824-1577
University of California - Irvine
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ers from Virginia Commonwealth University Medical ... oxidation of polyunsaturated fatty acids (PUFA) i...fatty liver (NAFL) to nonalcoholic steatohepatitis...er plasma monounsaturated fatty acids in the blood...pear in the December issue of Hepatology , a jour...
(Date:11/23/2009)... from women,s hair loss for almost ten years, Zsan...ng her progress and the secret behind her success ...of her video diaries which include a direct compar... , (PRWeb UK) November 23,...klosi has released the video diaries that document...
(Date:11/23/2009)...sintheRecommendedPriorityGroups ,, HARRISBURG,P...fHealthannouncedtodaytheywillconductthreeadditiona...Delaware,Lancaster,andLehighcountiesonTuesday,Nov....teredforfreetoindividualsintherecommendedtargetgro...artmentasksthatonlyindividualsinthefollowinggroups...
(Date:11/23/2009)...ls enjoy a pay raise for a job well done. But in s...e performance may actually backfire. , A new ...ings for 25 medical groups across California impro...ide pay-for-performance program in 2004 but not w... , Reporting in the December edition of the Jo...
(Date:11/23/2009)...the agency, said lives could be at risk , ...t from last week,s controversial recommendation th...ing for breast cancer continues, with a former hea...ng women to ignore the guidelines. , "I,m sayin...ly this will increase the number of women dying of...
Breaking Medicine News(10 mins):Health News:Metobolomics uncovers key indicators of nonalcoholic fatty liver disease 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3
...pulations at Greatest Risk for Developing End Stag...currently suffer from Kidney Disease, WASHINGTON,...wide coalition of patient advocates, dialysis,prof...e (CKD), today at an educational briefing on Capit...
... A Major Overhaul of Medicare, LEBANON, N.H., Apr... doctors more than the most efficient and effectiv...l people, yet gets worse,results, according to a n...d-standard health care systems such as the Mayo Cl...
...ood vessels that lose their ability to protect the...velopment of amyotrophic lateral sclerosis, better... research published in the April issue of Nature N...e unexpected finding opens up a new front in studi...
...RANCISCO, Calif., April 7, 2008 Hyperion,Therapeu...pany, today,announced that Lota S. Zoth has been e...th formerly served as Senior Vice President and Ch...n/prnh/20070905/AQW076LOGO ), In discussing her a...
... Calif., April 7, 2008 Exponent,Inc. (Nasdaq: EX...ial,results for the first quarter ended March 28, ...t on Monday, April 14, 2008. The Company will host...cer, and Richard Schlenker, Chief Financial Office...
...ce You are Willing to Pay, HUNTINGTON BEACH, Cali...uxury in the best or worst of times. "Make no mist...eir appearance with cosmetic,surgery "says Angela ...ue for the investment they are making in themselve...
Other Medicine News:Health News:Kidney Community Gathers on Capitol Hill to Ask Congress to Support Legislation for Increased Kidney Care Education, Updates for Kidney Dialysis Benefit 2Health News:Kidney Community Gathers on Capitol Hill to Ask Congress to Support Legislation for Increased Kidney Care Education, Updates for Kidney Dialysis Benefit 3Health News:Chronically Ill Patients Get More Care, Less Quality, Says Latest Dartmouth Atlas 2Health News:Chronically Ill Patients Get More Care, Less Quality, Says Latest Dartmouth Atlas 3Health News:Chronically Ill Patients Get More Care, Less Quality, Says Latest Dartmouth Atlas 4Health News:Chronically Ill Patients Get More Care, Less Quality, Says Latest Dartmouth Atlas 5Health News:Chronically Ill Patients Get More Care, Less Quality, Says Latest Dartmouth Atlas 6Health News:Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease 2Health News:Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease 3Health News:Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease 4Health News:Hyperion Therapeutics Elects Lota Zoth to Board of Directors 2Health News:5 Ways to Get the Plastic Surgery That You Want 2
(Date:11/23/2009)..., LASVEGAS,Nov.23/PRNewswire-FirstCall/--CordBlood...rdbloodstemcellpreservationcompany( http://www.cor...potentialofstemcells,abiologicalinsurancepolicy,to...ythatanupdatedprogressinterviewwithCEOandco-founde...terviewisat: http://blip.tv/file/2875811 . ,, I...
(Date:11/23/2009)..., PRINCETON,N.J.,Nov.23/PRNewswire-FirstCall/--Pha...rollmentofCohort2,ledbyitspartnerRoche(SWX:ROG.VX;...notype1and4patientsintheongoingphase2btrialofRG712...orforthetreatmentofchronichepatitisCvirus(HCV)infe...anindependentDataMonitoringCommittee(DMC)ofallavai...
(Date:11/23/2009)..., NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/--Rapt...aq: RPTP ),todayannouncedresultsfromaPhase2bclinic...tartrate("DRCysteamine")inpatientswithnephropathic...iversityofCalifornia,SanDiego("UCSD")GeneralClinic...macokineticsandpharmacodynamicsofasingledoseofDRCy...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday July 30 at 5 3A00 p m ET 2823 3A00 CET 29 50515 1BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday July 30 at 5 3A00 p m ET 2823 3A00 CET 29 50515 2Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 1Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 2Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 3Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 4Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 5Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 6Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 7Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 8Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 9Antibiotics May Boost Risk for Recurrent Ear Infection 50511 1Antibiotics May Boost Risk for Recurrent Ear Infection 50511 2
...SNO, Calif., Oct. 29 Cypress Systems, Inc., a Fre...t the SELECT TRIAL results --,that were announced ...nomethionine. The SELECT TRIAL found no effects of...ence of prostate cancer. See,Related Website at h...LECT TRIAL are consistent with previous animal,stu...
...ANSE is the first oral ADHD stimulant medication w...t 13 hours post-dose in a pediatric clinical,study...SHPGY), the global specialty biopharmaceutical com...g classroom study in school-aged children aged,6 t...sorder (ADHD). In this,study, researchers found th...
Other Medicine Technology:SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc. 2Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 2Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 3Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 4Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 5Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 6Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 7
Spinchron 15 Refrigerated Centrifuge
Adams Compact II
Dynac III
Rotanta 460
Medicine Products: